METHOTREXATE SUBCUTANEOUS
ACCORD HEALTHCARE INC
Quick answers
Is there a shortage of METHOTREXATE SUBCUTANEOUS in Canada?
No. There is no current shortage of METHOTREXATE SUBCUTANEOUS 12.5MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
METHOTREXATE INJECTION USP
PFIZER CANADA ULC
METHOTREXATE SODIUM INJECTION USP
PFIZER CANADA ULC
METHOTREXATE INJECTION, BP
PHARMASCIENCE INC
METOJECT
MEDEXUS PHARMACEUTICALS INC.
METHOTREXATE PF/SA INJECTION
SANDOZ CANADA INCORPORATED
METOJECT SUBCUTANEOUS
MEDEXUS PHARMACEUTICALS INC.
DIN
02491303
Strength
12.5MG
Dosage Form
Solution
Route
Subcutaneous
Active Ingredient
METHOTREXATE (METHOTREXATE SODIUM)
See all METHOTREXATE (METHOTREXATE SODIUM) products →Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from ACCORD HEALTHCARE INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
5MG · DIN 02381478
10MG · DIN 02381486
70MG · DIN 02381494
5MG · DIN 02419564
2.5MG · DIN 02419556
10MG · DIN 02419572
1MG · DIN 02351218
5MG · DIN 02487721
2.5MG · DIN 02487713
40MG · DIN 02457776
80MG · DIN 02457784
10MG · DIN 02457741